查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423584

2030 年支气管镜市场预测：按产品类型、组件、用途、应用、最终用户和地区进行的全球分析

Bronchoscopy Market Forecasts to 2030 - Global Analysis By Product Type (Bronchoscopes), By Component (Imaging Systems, Accessories and Other Components) Usage, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球支气管镜市场规模为 27 亿美元，预计在预测期内复合年增长率为 9.9%，到 2030 年将达到 53 亿美元。

支气管镜检查是一种医疗程序，可让您查看并评估您的肺部和气道。支气管镜是一根细而柔韧的管子，可透过您的口腔或鼻子插入喉咙，然后进入呼吸道。支气管镜检查可以直接观察呼吸系统，从而可以治疗和诊断各种肺部疾病。

根据国际呼吸学会论坛2022年报告，估计约有2亿人患有慢性阻塞性肺病，2.62亿人患有气喘。由于此类呼吸系统疾病的高盛行率和癌症患者数量的不断增加，预计用于诊断这种疾病的支气管镜检查的需求将会增加，并最终推动市场的发展。

呼吸系统疾病和肺部负担增加

肺癌、慢性阻塞性肺病(COPD)、气喘、肺炎和结核病等呼吸系统疾病的盛行率不断增加，增加了对支气管镜检查等诊断程序的需求。支气管镜检查对于获取组织样本和评估气道以进行正确诊断也至关重要，因为这些疾病通常需要准确的分期和诊断。随着患者在肺部相关疾病方面偏好转向侵入性较小的方法，支气管镜检查提供了开放性手术的替代方案，从而促进了市场成长。

製造成本高、应用困难

管理费用的急剧上升可能会导致用于支付这些费用的程序和课税价格上涨。这可能会增加患者、保险公司和政府医疗保健计划的费用，从而对医疗保健预算以及付款人和患者的负担能力产生负面影响。在管理费用过高的地区，提供支气管镜检查的医院较少，导致支气管镜检查分布不均。因此，先进诊断和治疗性支气管镜检查服务的可用性可能存在差异，这可能会影响患者护理。

支气管镜检查的技术进步

先进的支气管镜技术可以实现气道内的各种治疗方法，包括消融、支气管热成形术、切片检查、支架置入、肿瘤切除和去除异物。这些功能增加了支气管镜检查在治疗应用上的效用，并将其扩展到非诊断应用。此外，虚拟支气管镜和现代成像设备，包括电磁导航支气管镜（ENB）和支气管内超音波（EBUS），可以对气道和周围结构进行全面、即时的成像，推动市场成长。我们对此表示支持。

併发症的风险

医疗机构和提供者可能会因支气管镜检查手术后的併发症而面临责任问题。医疗保健专业人员必须遵守严格的护理标准和通讯协定，以减少困难并防止潜在的诉讼。这增加了支气管内治疗的复杂性和谨慎性。如果出现问题，可能会引起监管机构的注意，监管机构可能会对支气管镜检查实施更严格的政策和品管流程。为了保持合规性，医疗保健组织可能必须证明他们遵循严格的指导方针，这可能会影响他们的运作方式和资源使用方式，从而阻碍市场成长。这是有可能的。

COVID-19 的影响

支气管镜检查会产生气溶胶，使医护人员容易受到感染。因此，正在采取措施减少病毒传播的可能性，例如使用一次性支气管镜、支气管镜检查前进行PCR检测以及个人防护设备。支气管镜检查服务和设备的可得性和需求受到这些实践变化的影响。然而，效用仍存在争议，因为支气管镜检查具有显着的感染风险。需要进一步研究来确定大流行对支气管镜市场的长期影响。

支气管镜检查部分预计将在预测期内成为最大的部分

由于先进的支气管镜检查提供了广泛的介入治疗，如切片检查、切除技术、治疗治疗性介入、去除异物和支架置入，预计支气管镜检查领域将出现良好的增长。由于支气管镜检查在执行治疗和诊断治疗方面的多功能性，市场需求不断增加。製造商生产和销售更复杂的支气管镜的竞争力不断增强，正在刺激该行业的创新。因此，公司正在努力推出新的配件、功能和技术，透过改进和差异化的产品来增加市场占有率。

预测期内，支气管诊断领域预期复合年增长率最高

预计支气管诊断领域在预测期内将以最高复合年增长率成长。支气管诊断领域协助医生识别肺部疾病的阶段、类型和特征，以便提供个人化和针对性的治疗，例如化疗、放射线治疗、放射标靶治疗和标靶治疗。医疗保健专业人员越来越依赖支气管镜检查来准确、及时地诊断呼吸系统疾病，这推动了对支气管诊断程序和支气管镜检查市场的需求。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。这是由于北美癌症发生率上升以及微创手术日益普及等因素所造成的。此外，医学影像技术的重大开拓也推动了市场的发展，它使得标靶癌症治疗成为可能，并使介入肿瘤学家能够将影像引导治疗纳入日常临床实践。此外，根据加拿大癌症协会2022年11月发布的统计数据，预计当年将有233,900名加拿大人被诊断出罹患癌症。癌症发生率的增加凸显了预防癌症的必要性，这主要是由于加拿大的老化和人口不断增加。

复合年增长率最高的地区：

由于政府努力增加癌症治疗资金、尖端治疗方法和产品的商业化以及围绕其开发的监管支持，预计亚太地区在预测期内的复合年增长率最高。在中国、日本和印度等国家设有研究中心。此外，一些国家有前景的报销制度和法律规范正在促进支气管镜手术的普及，并促进该地区的市场成长。

免费客製化服务：

如果您订阅此报告，我们将为您提供以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球支气管镜市场：依产品类型

  • 支气管镜
    • 死板的
    • 灵活的
    • 支气管内超音波（EBUS）

第六章全球支气管镜市场：依组成部分

  • 影像系统
    • 光源
    • 视讯处理器
    • 相机镜头
    • 无线显示和监控
  • 配件
    • 喉舌
    • 清洁刷
    • 切片检查阀
    • 经支气管细针抽吸
    • 细胞刷
    • 切片检查钳
    • 其他配件
  • 其他组件

第七章全球支气管镜市场：依用途

  • 一次性的
  • 可重复使用的

第八章全球支气管镜市场：依应用分类

  • 支气管治疗
  • 支气管诊断

第九章全球支气管镜市场：依最终用户分类

  • 医院
  • 门诊手术中心
  • 其他最终用户

第十章全球支气管镜市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Boston Scientific
  • Cook Medical
  • Ethicon.Inc
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • Roper Technologies
  • Teleflex Incorporated.
  • Medtronic
  • Lymol Medical
  • Hoya Corporation
  • Karl Storz
  • AMBU A/S
  • Conmed Corporation
  • Broncus Medical Inc.
  • Novatech SA
  • Pentax Medical
Product Code: SMRC24818

According to Stratistics MRC, the Global Bronchoscopy Market is accounted for $2.7 billion in 2023 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 9.9% during the forecast period. A bronchoscopy is a medical treatment that allows one to see and assess the lungs and airways. Bronchoscope is a device, which is a thin, flexible tube that is inserted into the mouth or nose, down the throat, and into the airways. Direct vision of the respiratory system is made possible by bronchoscopy, which enables treatment and diagnostic procedures for a range of lung diseases.

According to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million are affected by Asthma. With such a high prevalence of respiratory disease and a rise in cancer cases, the demand for bronchoscopes is expected to increase to diagnose this disease, eventually driving the market.

Market Dynamics:

Driver:

Growing burden of respiratory diseases and lung

There is a growing need for diagnostic procedures like bronchoscopies due to the rising prevalence of respiratory disorders such lung cancer, chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and TB. In addition, the bronchoscopy is essential for collecting tissue samples and assessing the airways in order to provide an appropriate diagnosis since these illnesses frequently need for precise staging and diagnosis. When it comes to lung-related illnesses, bronchoscopy presents an option to open operations as patient preferences move toward less intrusive methods boosting the market growth.

Restraint:

High production costs and difficulty in application

Elevated overhead costs might result in higher prices for procedures or levies to pay for these outlays. This may have an adverse effect on healthcare budgets and affordability for payers and patients equally by raising expenses for patients, insurance companies, or government healthcare programs. There may be an unequal distribution of bronchoscopy services, with fewer hospitals providing these procedures, in areas where overhead costs are too high. Patient treatment may be impacted by differences in availability to sophisticated diagnostic and therapeutic bronchoscopy services as a result of this.

Opportunity:

Technological advancements in bronchoscopy

Various therapeutic treatments within the airways, including ablation methods, bronchial thermoplasty, biopsies, stent placements, tumor removal, and the removal of foreign materials, are made possible by advanced bronchoscope technology. These features raise the bronchoscopy's utility for therapeutic applications and broaden its application beyond diagnosis. Furthermore, the comprehensive, real-time imaging of the airways and surrounding structures is made possible by virtual bronchoscopy and modern imaging modalities including electromagnetic navigation bronchoscopy (ENB) and endobronchial ultrasound (EBUS) thereby encouraging in the market growth.

Threat:

Risk of complications

Healthcare institutions and providers may face legal and liability issues as a result of complications following bronchoscopy operations. The adherence to stringent standards of care and protocols by healthcare practitioners is necessary in order to mitigate difficulties and prevent potential lawsuits. This adds to the intricacy and caution associated with executing these treatments. Instances of problems might draw regulatory attention, leading authorities to enforce more stringent policies or quality control processes for bronchoscopy operations. To remain compliant, healthcare institutions could have to show that they are following strict guidelines, which might have an impact on how well they operate and how they use their resources impeding the growth of the market.

Covid-19 Impact

Healthcare personnel are more vulnerable to infection during bronchoscopy procedures because of their aerosol-generating nature. Consequently, steps have been taken to lower the possibility of viral transmission, including the use of disposable bronchoscopes, pre-bronchoscopy PCR testing, and personal protective equipment. The availability and demand for bronchoscopy services and equipment have been impacted by these changes in practice. However, because bronchoscopy has a considerable risk of infection, its usefulness in diagnosing COVID-19 is still up for discussion. To determine the pandemic's long-term effects on the bronchoscopy market, more investigation is required.

The bronchoscopes segment is expected to be the largest during the forecast period

The bronchoscopes segment is estimated to have a lucrative growth, because advanced bronchoscopes provide a broad spectrum of interventional treatments, including biopsies, ablative methods, therapeutic interventions, foreign body removal, and stent installation. The market demand for bronchoscopes has increased due to its versatility in conducting both therapeutic and diagnostic treatments. Industry innovation has been spurred by manufacturers' increased competitiveness to create and market more sophisticated bronchoscopes thus businesses work hard to launch new accessories, features, and technology in an effort to expand their market share through improved and differentiated products.

The bronchial diagnosis segment is expected to have the highest CAGR during the forecast period

The bronchial diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period, in order to provide individualized and targeted therapies, such as surgery, chemotherapy, radiation, or targeted therapies; it assists doctors in identifying the stage, type, and features of lung illnesses. Healthcare professionals are increasingly depending on bronchoscopy for precise and timely diagnosis of respiratory disorders, which is driving the demand for bronchial diagnostic procedures and the bronchoscopy market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to factors like the rising incidence of cancer in the nation, the growing popularity of minimally invasive procedures. Moreover, the market is being driven by the fact that notable developments in medical imaging technology have made targeted cancer therapy possible and enabled interventional oncologists to incorporate image-guided treatments into routine clinical practice. In addition, statistics released by the Canadian Cancer Society in November 2022 predicted that 233,900 Canadians will receive a cancer diagnosis that year. The need of cancer prevention is highlighted by this increase in incidence, which is mostly attributable to Canada's aging and expanding population.

Region with highest CAGR:

Asia-Pacific is projected to have the highest CAGR over the forecast period, owing to government's initiatives to increase funding for cancer treatments, the commercialization of cutting-edge procedures and products and the supportive regulations surrounding their development, rising healthcare spending, and the expansion of research bases in nations such as China, Japan, and India. Additionally the promising reimbursement systems and regulatory frameworks in several nations have facilitated the uptake of bronchoscopy operations encourage the growth of the market in this region.

Key players in the market

Some of the key players profiled in the Bronchoscopy Market include Boston Scientific, Cook Medical, Ethicon.Inc, Fujifilm Holdings Corporation, Olympus Corporation, Richard Wolf GmbH, Roper Technologies, Teleflex Incorporated., Medtronic, Lymol Medical, Hoya Corporation, Karl Storz, AMBU A/S, Conmed Corporation, Broncus Medical Inc., Novatech SA and Pentax Medical

Key Developments:

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

Product Types Covered:

  • Bronchoscopes

Components Covered:

  • Imaging Systems
  • Accessories
  • Other Components

Usages Covered:

  • Disposable
  • Reusable

Applications Covered:

  • Bronchial Treatment
  • Bronchial Diagnosis

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bronchoscopy Market, By Product Type

  • 5.1 Introduction
  • 5.2 Bronchoscopes
    • 5.2.1 Rigid
    • 5.2.2 Flexible
    • 5.2.3 Endobronchial Ultrasound (EBUS)

6 Global Bronchoscopy Market, By Component

  • 6.1 Introduction
  • 6.2 Imaging Systems
    • 6.2.1 Light Sources
    • 6.2.2 Video Processors
    • 6.2.3 Camera Heads
    • 6.2.4 Wireless Displays & Monitors
  • 6.3 Accessories
    • 6.3.1 Mouthpieces
    • 6.3.2 Cleaning Brushes
    • 6.3.3 Biopsy Valves
    • 6.3.4 Transbronchial Aspiration Needles
    • 6.3.5 Cytology Brushes
    • 6.3.6 Biopsy Forceps
    • 6.3.7 Other Accessories
  • 6.4 Other Components

7 Global Bronchoscopy Market, By Usage

  • 7.1 Introduction
  • 7.2 Disposable
  • 7.3 Reusable

8 Global Bronchoscopy Market, By Application

  • 8.1 Introduction
  • 8.2 Bronchial Treatment
  • 8.3 Bronchial Diagnosis

9 Global Bronchoscopy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Other End Users

10 Global Bronchoscopy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific
  • 12.2 Cook Medical
  • 12.3 Ethicon.Inc
  • 12.4 Fujifilm Holdings Corporation
  • 12.5 Olympus Corporation
  • 12.6 Richard Wolf GmbH
  • 12.7 Roper Technologies
  • 12.8 Teleflex Incorporated.
  • 12.9 Medtronic
  • 12.10 Lymol Medical
  • 12.11 Hoya Corporation
  • 12.12 Karl Storz
  • 12.13 AMBU A/S
  • 12.14 Conmed Corporation
  • 12.15 Broncus Medical Inc.
  • 12.16 Novatech SA
  • 12.17 Pentax Medical

List of Tables

  • Table 1 Global Bronchoscopy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bronchoscopy Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bronchoscopy Market Outlook, By Bronchoscopes (2021-2030) ($MN)
  • Table 4 Global Bronchoscopy Market Outlook, By Rigid (2021-2030) ($MN)
  • Table 5 Global Bronchoscopy Market Outlook, By Flexible (2021-2030) ($MN)
  • Table 6 Global Bronchoscopy Market Outlook, By Endobronchial Ultrasound (EBUS) (2021-2030) ($MN)
  • Table 7 Global Bronchoscopy Market Outlook, By Component (2021-2030) ($MN)
  • Table 8 Global Bronchoscopy Market Outlook, By Imaging Systems (2021-2030) ($MN)
  • Table 9 Global Bronchoscopy Market Outlook, By Light Sources (2021-2030) ($MN)
  • Table 10 Global Bronchoscopy Market Outlook, By Video Processors (2021-2030) ($MN)
  • Table 11 Global Bronchoscopy Market Outlook, By Camera Heads (2021-2030) ($MN)
  • Table 12 Global Bronchoscopy Market Outlook, By Wireless Displays & Monitors (2021-2030) ($MN)
  • Table 13 Global Bronchoscopy Market Outlook, By Accessories (2021-2030) ($MN)
  • Table 14 Global Bronchoscopy Market Outlook, By Mouthpieces (2021-2030) ($MN)
  • Table 15 Global Bronchoscopy Market Outlook, By Cleaning Brushes (2021-2030) ($MN)
  • Table 16 Global Bronchoscopy Market Outlook, By Biopsy Valves (2021-2030) ($MN)
  • Table 17 Global Bronchoscopy Market Outlook, By Transbronchial Aspiration Needles (2021-2030) ($MN)
  • Table 18 Global Bronchoscopy Market Outlook, By Cytology Brushes (2021-2030) ($MN)
  • Table 19 Global Bronchoscopy Market Outlook, By Biopsy Forceps (2021-2030) ($MN)
  • Table 20 Global Bronchoscopy Market Outlook, By Other Accessories (2021-2030) ($MN)
  • Table 21 Global Bronchoscopy Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 22 Global Bronchoscopy Market Outlook, By Usage (2021-2030) ($MN)
  • Table 23 Global Bronchoscopy Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 24 Global Bronchoscopy Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 25 Global Bronchoscopy Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 Global Bronchoscopy Market Outlook, By Bronchial Treatment (2021-2030) ($MN)
  • Table 27 Global Bronchoscopy Market Outlook, By Bronchial Diagnosis (2021-2030) ($MN)
  • Table 28 Global Bronchoscopy Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Bronchoscopy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Bronchoscopy Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 31 Global Bronchoscopy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.